Study Evaluating 5 Doses of RPL554 and Placebo in COPD Patients Via a Dry Powder Inhaler
Condition: Pulmonary Disease, Chronic Obstructive Interventions: Drug: Part A: RPL554; Drug: Part B: RPL554; Drug: Placebos Sponsors: Verona Pharma plc; Iqvia Pty Ltd Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials